Metrics to compare | CURA | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCURAPeersSector | |
|---|---|---|---|---|
P/E Ratio | −11.1x | −2.1x | −0.5x | |
PEG Ratio | 0.95 | 0.00 | 0.00 | |
Price / Book | 3.6x | 0.6x | 2.6x | |
Price / LTM Sales | 2.2x | 1.6x | 3.2x | |
Upside (Analyst Target) | 5.8% | 68.0% | 48.8% | |
Fair Value Upside | Unlock | 18.3% | 6.9% | Unlock |
Curaleaf Holdings, Inc. engages in the retail and wholesale of cannabis products in the United States and internationally. The company operates licensed cultivation; and pharma-grade cannabis processing and manufacturing facilities. It also supplies cannabis on a wholesale basis to Australia, New Zealand, the United Kingdom and various European countries, including Germany, Italy, Poland, the Czech Republic, Switzerland, Sweden and Norway. In addition, the company operates a medical cannabis clinic and holds a pharmacy license. It serves the medical and adult-use cannabis markets through retail and wholesale channels. The company is based in Stamford, Connecticut.